Description
Yeslie Ruiz Gomez
Managing peptic ulcer disease may require adjustments to patients’ treatment plans over time due to changes in their symptom severity, underlying health conditions, or comorbidities. Discuss the process of evaluating and monitoring patients with peptic ulcer disease to determine the most appropriate treatment plan and when modifications may be necessary.
Peptic ulcer disease is a complex and intriguing gastrointestinal illness that requires healthcare professionals to be adamant in its evaluation and management. Patients affected by the condition often suffer from severe symptoms and other health conditions (Laucirica et al., 2023). For this reason, healthcare providers must continually monitor and assess these patients to ensure they receive the most effective treatment plan. I will analyze the procedures of evaluating and monitoring peptic ulcer disease and discuss plausible modifications to patient treatment plans where necessary.
When a patient with peptic ulcer disease is admitted for healthcare service, practitioners go through various diagnosis processes to evaluate clinical symptoms (Lee et al., 2022). Using endoscopy, Helicobacter testing, and optic imaging procedures helps healthcare professionals identify crucial symptoms and factors contributing to the progression of the disease. A patient’s lifestyle choices, genetic history, and medical history are analyzed to facilitate the initiation of an appropriate treatment plan (Lee et al., 2022). Initial medical treatments may involve interventions, prescription drugs such as antacids, proton pump inhibition method, and Helicobacter pylori eradication.
However, the treatment, as mentioned earlier, plans are only a prerequisite, and regular follow-up appointments and checkups are essential to continue monitoring the patient’s progress and possible outcomes (Luo et al., 2022). Healthcare providers must assess the patient’s drug adherence and repeatedly conduct endoscopic testing to look for complications. They may modify a patient’s treatment plans to relieve symptoms and reduce severity by adjusting the drug doses, changing the drugs themselves, or even performing surgical operations to alleviate the most severe cases (Luo et al., 2022). Patients require education and professional guidance to manage peptic ulcer disease effectively.
Candice Rawlins
Prompt #2 The treatment of hepatitis, a viral infection affecting the liver, has evolved significantly over the past few decades with the introduction of new antiviral agents. Select and discuss one of the different classes of drugs used to treat various types of hepatitis (e.g., hepatitis B and C), their mechanisms of action, and the factors healthcare professionals must consider when selecting the most appropriate treatment regimen for a specific patient, such as the viral genotype, disease stage, and potential drug interactions.
Over recent years, there have been advancements in treating hepatitis B and C variants. Such drugs include nucleoside/nucleotide analogs for hepatitis B and direct-acting antivirals (DAAs) for hepatitis C. Nucleoside/nucleotide analogs for hepatitis B act by inhibiting the reverse transcriptase enzyme, which is crucial for viral replication and thus is incorporated into the growing viral DNA chain, causing premature termination (Zenchenko et al., 2021). It is essential to consider the viral genotypes of hepatitis B since each variant responds differently to treatment. Furthermore, we should consider the disease stage or severity, potential drug interactions, and renal and hepatic function to ensure correct dose adjustments and monitor treatment efficacy. Furthermore, it is crucial to monitor medication resistance since the patient may resist the drug over time. Direct-acting antivirals (DAAs) target specific viral proteins essential for replication of the hepatitis C virus. They also inhibit viral replication at various stages in the lifecycle (Dietz & Maasoumy, 2022). To ensure better health outcomes, it is crucial to consider viral genotypes to ensure the correct choice of DAA. Additionally, considering disease severity or stage helps determine the treatment duration. Furthermore, it is crucial to consider prior treatment history and possible drug interactions to monitor for treatment response. Therefore, it is essential to develop a personalized treatment plan to optimize treatment outcomes for hepatitis patients.
